Insurance insights: Medical malpractice matters, April 2026
Welcome to the latest edition of Medical Malpractice Matters.
This edition arrives at a moment when the forces reshaping healthcare - technology, regulation, clinical innovation, and an increasingly assertive patient population - are converging with unusual speed. The five articles collected here reflect that reality head on.
We begin with a sharp look at AI and the litigant in person - a phenomenon the courts are already grappling with. AI-generated pleadings, hallucinated citations, and sensitive clinical records pasted into public chatbots: the risks are real and growing, and this article offers practical guidance for defendants navigating them.
From there, we turn to group actions and the insurance implications of Ahmed and Others v White & Co, a Commercial Court decision with important lessons on notification of circumstances for anyone operating on claims-made terms - lessons that translate directly into the medical malpractice context.
Our third piece examines the Government's refreshed Women's Health Strategy, and what clearer clinical pathways and a renewed political commitment to taking women's symptoms seriously means for the claims landscape - for better and, potentially, for worse.
The fourth article shines a light on extravasation injury in the booming cosmetic IV therapy market - a largely unregulated space where clinical risk and litigation exposure are both significantly underestimated.
We close with GLP-1 weight loss drugs: the fastest growing area of prescribing in modern medicine and, with over 3,300 lawsuits already filed in the United States, potentially the next major frontier of clinical negligence litigation in this jurisdiction.
We hope you find this edition as thought-provoking to read as it was to compile.
Contents
- AI and the Litigant in Person: Risks for clinical negligence defendants
- Block notifications, group actions, and the lessons of Ahmed v White & Co for medical malpractice in
- Women's Health Strategy 2026: Implications for NHS providers
- Extravasation in cosmetic IV therapy: Managing legal risk
- GLP-1 weight loss drugs: Managing legal risk for prescribers
Contact
Bethan Parry
Partner
bethan.parry@brownejacobson.com
+44 (0)330 045 1351
You may be interested in
Insurance insights: Medical malpractice matters, April 2026
AI and the Litigant in Person: Risks for clinical negligence defendants
Women's Health Strategy 2026: Implications for NHS providers
Extravasation in cosmetic IV therapy: Managing legal risk
Block notifications, group actions, and the lessons of Ahmed v White & Co for medical malpractice insurers
GLP-1 weight loss drugs: Managing legal risk for prescribers
What the care leaver deaths review means for local authorities and what to do now
Meningitis outbreaks are back on the liability radar: How might this impact insurers?
When is court approval required for a looked after child's medical treatment?
MRO fees capped at 25%: What defendants need to know following JXX v Archibald
Secondary victim claims in clinical negligence: No recovery following birth injury
The CMA is watching private dentistry: Indemnifiers and insurers should too
MNSI data shows a fall in reported cases of HIE in England
Independent Investigation into Maternity and Neonatal Services Interim Report: Proactive steps for NHS Trusts
Rehman v Secretary of State for Health and Social Care & Others: Covid-19 care home claims struck out
High Court ruling saves fertility patients’ chance of parenthood
Medical malpractice
Independent Investigation into Maternity and Neonatal Services Interim Report: Key findings and next steps
“Lost years” claims by child claimants permitted by the Supreme Court
Browne Jacobson barrister and solicitor appointed as Deputy District Judges
Newsletter guidance for healthcare providers on PSIRF and inquests
The importance of empathetic language in historical abuse claims
Insurance insights: Medical malpractice matters, January 2026
Damned if they do, damned if they don’t: Understanding and mitigating the risk of AI tools in healthcare practice
Management of group action claims in medical negligence: An introductory guide for defendant insurers, indemnifiers
Healthcare insurers and indemnifiers: Post-2025 litigation learning
Treatment as team effort: Medical and dental patient responsibility
Medical tourism on the rise: What UK-based insurers need to know
Private fertility clinics: Increasing incidents in ‘very safe’ sector
Supreme Court ruling: Illegality defence applies despite insanity acquittal
Spotlight on: Jenny Harrington, Senior Associate
Illegal teeth-whitening: A growing risk for beauty salon insurers
Current life sciences insurance trends and the imperative for specialised coverage
Rise in illegal teeth whitening kits: Serious risk to dental health
Shared insights: Corporate and gross negligence manslaughter in the health and care sector
World Prematurity Day 2025: Support for the tiniest fighters
NAO clinical negligence costs report: Medical malpractice insights
Shaping the future of maternity care: Reflections from Baby Lifeline
AI in neurorehabilitation: Opportunities for earlier, needs-based support
